SOLTI-0701: A multinational double-blind, randomized phase 2b study evaluating the efficacy and safety of Sorafenib compared to Placebo in combination with Capecitabine in patients with locally advanced or metastatic breast cancer
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.